CDKN1C and neoplasm: For instance, miR-224 increases tumor cell progression by inhibiting the expression of apoptosis inhibitor-5 [18,44], and miR-221 promotes cell proliferation by controlling the cell cycle inhibitors (CDKI) CDKN1C/p57 and CDKN1B/p27 [42].